Cognition Therapeutics, Inc. (CGTX) vs Inovio Pharmaceuticals, Inc. (INO)
A side-by-side comparison of Cognition Therapeutics, Inc. and Inovio Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGTX
Cognition Therapeutics, Inc.
$0.94HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
INO
Inovio Pharmaceuticals, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 1:25 PM EDT
Total return — CGTX vs INO
growth of $100 · dividends reinvested · last 5yCGTX -92.7% (-40.7%/yr)INO -98.7% (-57.8%/yr)CGTX compounded faster over this window
Log scale — wide-divergence pair
CGTX INO
CGTX vs INO: by the numbers
- •CGTX is the larger company ($84M vs $78M market cap).
- •Both run net losses; CGTX's is the smaller (0.00% vs -130000.00% net margin).
Metrics side by side
Valuation
| Metric | CGTX | INO |
|---|---|---|
| P/B ratio | 2.55 | 17.86 |
Profitability
| Metric | CGTX | INO |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -132871.32% |
| Net margin | 0.00% | -130000.00% |
| ROE | -50.80% | -1542.57% |
| ROIC | -109.43% | -836.58% |
Growth (annualized)
| Metric | CGTX | INO |
|---|---|---|
| Total return CAGR (5Y) | N/A | -57.05% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.